FOI.ICB-2627/103: Hereditary Angioedema (HAE) High-cost-drug (Blueteq) Approvals FOI.ICB-2627/103: Hereditary Angioedema (HAE) High-cost-drug (Blueteq) Approvals Filename: FOI.ICB-2627_103-HAE-HIGH-COST-DRUG-BLUETEQ-APPROVALS-FINAL-RESPONSE.PDF File type: PDF File size: 250 KB Download